Biliary hCGβ Is a Potential Novel Marker for Prediction of Biliary Neoplasia in Primary Sclerosing Cholangitis Patients

Biliary hCGβ Is a Potential Novel Marker for Prediction of Biliary Neoplasia in Primary Sclerosing Cholangitis Patients

Primary sclerosing cholangitis (PSC) is a chronic inflammatory disease, which is associated with an increased risk of cholangiocarcinoma (CCA). Novel markers, to complement or replace CA19-9, are urgently needed for the screening of PSC-associated biliary neoplasia. Previous studies have suggested t...

Full description

Bibliographic Details
Main Authors: Hannu Koistinen, Sonja Boyd, Johanna Arola, Kalle Jokelainen, Riitta Koistinen, Anna Lempiäinen, Kristina Hotakainen, Ulf-Håkan Stenman, Martti Färkkilä
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Livers
Subjects:
cholangitis
sclerosing
cholangiocarcinoma
hCG-beta
biochemical markers
bile
Online Access:https://www.mdpi.com/2673-4389/1/4/25

Internet

https://www.mdpi.com/2673-4389/1/4/25

Similar Items